These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8472916)
1. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin. Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916 [TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin. Qadri F; Azim T; Hossain A; Islam D; Mondal G; Faruque SM; Albert MJ Adv Exp Med Biol; 1995; 371B():923-6. PubMed ID: 7502927 [No Abstract] [Full Text] [Related]
3. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin. Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402 [TBL] [Abstract][Full Text] [Related]
4. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. Brown JE; Griffin DE; Rothman SW; Doctor BP Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403 [TBL] [Abstract][Full Text] [Related]
5. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. O'Brien AD; Chen ME; Holmes RK; Kaper J; Levine MM Lancet; 1984 Jan; 1(8368):77-8. PubMed ID: 6140426 [TBL] [Abstract][Full Text] [Related]
6. High level expression of Shiga toxin B subunit of Shigella dysenteriae serotype 1 in Escherichia coli. Su G; Li F; Huang P; Rui X; Huang C Chin J Biotechnol; 1993; 9(1):49-55. PubMed ID: 8155839 [TBL] [Abstract][Full Text] [Related]
7. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin. Islam MS; Stimson WH J Clin Lab Immunol; 1990 Sep; 33(1):11-6. PubMed ID: 1966939 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of monoclonal antibodies to Shiga toxin. Griffin DE; Gentry MK; Brown JE Infect Immun; 1983 Jul; 41(1):430-3. PubMed ID: 6345399 [TBL] [Abstract][Full Text] [Related]
11. Production of Shiga toxin and other cytotoxins by serogroups of Shigella. Bartlett AV; Prado D; Cleary TG; Pickering LK J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154 [TBL] [Abstract][Full Text] [Related]
12. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552 [TBL] [Abstract][Full Text] [Related]
13. Localization of stx, a determinant essential for high-level production of shiga toxin by Shigella dysenteriae serotype 1, near pyrF and generation of stx transposon mutants. Sekizaki T; Harayama S; Brazil GM; Timmis KN Infect Immun; 1987 Sep; 55(9):2208-14. PubMed ID: 3040592 [TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides of Shiga toxin B-subunit induce antibodies which neutralize the biological activities of the toxin. Harari I; Donohue-Rolfe A; Keusch GT; Arnon R Ann Sclavo Collana Monogr; 1986; 3(1-2):125-30. PubMed ID: 3322336 [No Abstract] [Full Text] [Related]
15. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit. Wu T; Grassel C; Levine MM; Barry EM Infect Immun; 2011 Dec; 79(12):4912-22. PubMed ID: 21969003 [TBL] [Abstract][Full Text] [Related]
16. Potential virulence of viable but nonculturable Shigella dysenteriae type 1. Rahman I; Shahamat M; Chowdhury MA; Colwell RR Appl Environ Microbiol; 1996 Jan; 62(1):115-20. PubMed ID: 8572688 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies specific for Shigella dysenteriae serotype 13. Production, characterization, and diagnostic application. Qadri F; Azim T; Hossain A; Chowdhury A; Albert MJ Diagn Microbiol Infect Dis; 1994 Mar; 18(3):145-9. PubMed ID: 7924205 [TBL] [Abstract][Full Text] [Related]
18. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence. Neill RJ; Gemski P; Formal SB; Newland JW J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471 [TBL] [Abstract][Full Text] [Related]
20. Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo. Keren DF; Brown JE; McDonald RA; Wassef JS Infect Immun; 1989 Jul; 57(7):1885-9. PubMed ID: 2659525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]